Clinical Trial Update: Hypernatremia for the Prevention and Treatment of Cerebral Edema in Traumatic Brain Injury [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial investigating hypernatremia for prevention and treatment of cerebral edema in traumatic brain injury has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Contusion
• Cerebral Edema
• Subdural Hematoma
• Traumatic Brain Injury

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Traumatic Brain Injury, Subdural Hematoma | Phase 1, Phase 2 | Status: WITHDRAWN